Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Wilson

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of the American Chemical Society|June 29, 2019
Reactivity of an Unusual Amidase May Explain Colibactin's DNA Cross-Linking ActivityYindi Jiang, Alessia Stornetta, Peter W Villalta, et al.
British Journal of Haematology|June 26, 2023
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective studyMatthew R Wilson, Euan Haynes, Katrina Parsons, et al.
The Journal of Physical Chemistry. B|May 2, 2025
Theoretical Foundation for Interface-Specific Hyper-Rayleigh Scattering in Uniaxial Chiral AssembliesKevin Murati, Alexander J Higgins, Carly M Clisham, et al.
British Journal of Haematology|November 7, 2024
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice PaperAisling Barrett, Nimish Shah, Andrew Chadwick, et al.
Science (New York, N.Y.)|February 16, 2019
The human gut bacterial genotoxin colibactin alkylates DNAMatthew R Wilson, Yindi Jiang, Peter W Villalta, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
British Journal of Haematology|February 23, 2021
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patientsRory McCulloch, David Lewis, Nicola Crosbie, et al.
Hemasphere|June 14, 2024
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysisMaeve A O'Reilly, William Wilson, David Burns, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2021
Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailabilityKendarius J Butler, Angel A Castro, Tiffany S Dwyer, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|June 29, 2019
Reactivity of an Unusual Amidase May Explain Colibactin's DNA Cross-Linking ActivityYindi Jiang, Alessia Stornetta, Peter W Villalta, et al.
British Journal of Haematology|June 26, 2023
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective studyMatthew R Wilson, Euan Haynes, Katrina Parsons, et al.
The Journal of Physical Chemistry. B|May 2, 2025
Theoretical Foundation for Interface-Specific Hyper-Rayleigh Scattering in Uniaxial Chiral AssembliesKevin Murati, Alexander J Higgins, Carly M Clisham, et al.
British Journal of Haematology|November 7, 2024
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice PaperAisling Barrett, Nimish Shah, Andrew Chadwick, et al.
Science (New York, N.Y.)|February 16, 2019
The human gut bacterial genotoxin colibactin alkylates DNAMatthew R Wilson, Yindi Jiang, Peter W Villalta, et al.
The Lancet. Oncology|September 2, 2022
CNS prophylaxis for diffuse large B-cell lymphomaToby A Eyre, Kerry J Savage, Chan Y Cheah, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
British Journal of Haematology|February 23, 2021
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patientsRory McCulloch, David Lewis, Nicola Crosbie, et al.
Hemasphere|June 14, 2024
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysisMaeve A O'Reilly, William Wilson, David Burns, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2021
Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailabilityKendarius J Butler, Angel A Castro, Tiffany S Dwyer, et al.
Pageof 4